Per-Operative Radiotherapy by Papillon +TM in Localized Breast Cancer

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05296317` - Evaluation and Modeling of the Effect of G-CSF on the Evolution of Polynuclear Neutrophils During Dense Dose Epirubicin-Cyclophosphamide Regeneration	N/A
Active, not recruiting	`NCT03121469` - Technique of Per-Operative Radiotherapy (RPO) by Papillon +TM in Localized Breast Cancer	N/A
Recruiting	`NCT00651417` - Use of Organic Germanium or Placebo for the Prevention of Radiation Induced Fatigue	Phase 2

See also

Status

Clinical Trial

Phase

Recruiting

NCT05296317 - Evaluation and Modeling of the Effect of G-CSF on the Evolution of Polynuclear Neutrophils During Dense Dose Epirubicin-Cyclophosphamide Regeneration

N/A

Active, not recruiting

NCT03121469 - Technique of Per-Operative Radiotherapy (RPO) by Papillon +TM in Localized Breast Cancer

N/A

Recruiting

NCT00651417 - Use of Organic Germanium or Placebo for the Prevention of Radiation Induced Fatigue

Phase 2

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT04680715
Study type	Interventional
Source	Centre Antoine Lacassagne
Contact	Frédérique JACQUINOT
Phone	04 92 03 10 24
Email	drci-promotion@nice.unicancer.fr
Status	Recruiting
Phase	N/A
Start date	July 16, 2021
Completion date	June 2028

Per-Operative Radiotherapy by Papillon +TM in Localized Breast Cancer — RPOS+2

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms